SEC Form EFFECT filed by Myovant Sciences Ltd.
$MYOV
Biotechnology: Pharmaceutical Preparations
Health Care
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | March 16, 2023 |
Accession Number: | 0001140361-23-011050 | ||||||
Submission Type: | POS AM | ||||||
|